Baker Hughes
BKR
$64.27
-0.42%
Baker Hughes Company is a global energy technology firm operating in two core segments: Oilfield Services & Equipment (OFSE) and Industrial & Energy Technology (IET). As one of the 'Big Three' oilfield services players alongside SLB and Halliburton, it provides equipment, services, and digital solutions to hydrocarbon developers, while its IET segment focuses on turbines, compressors, and related services for broader industrial and energy applications. The current investor narrative is dominated by the company's strategic pivot to sharpen its focus on core energy markets, evidenced by the recent $1.45 billion sale of its non-core Waygate Technologies unit, and its positioning to capitalize on heightened geopolitical tensions in the Middle East, particularly the prolonged closure risk of the Strait of Hormuz, which is driving a risk premium in energy markets and demand for its services.…
BKR
Baker Hughes
$64.27
Related headlines
Investment Opinion: Should I buy BKR Today?
Rating & Thesis: Hold. Baker Hughes is a fundamentally sound company positioned in a favorable sector, but its valuation already reflects a significant earnings recovery, and recent technical weakness suggests near-term headwinds. The analyst consensus is bullish, but the stock requires a catalyst to break through resistance.
Supporting Evidence: The recommendation is supported by four key data points: 1) The forward PE of 22.96x prices in substantial growth, leaving limited margin of safety. 2) TTM Free Cash Flow of $2.54 billion and an ROE of 13.7% confirm high-quality profitability. 3) Revenue growth, while positive sequentially, remains modest at 0.3% YoY in Q4, questioning the pace of the top-line recovery. 4) The stock's severe relative underperformance (-13.5% vs. SPY over 1 month) indicates it is currently out of favor despite the positive fundamentals.
Risks & Conditions: The two biggest risks are failure to meet the $3.51 EPS estimate, triggering multiple compression, and a broader sector sell-off. This Hold rating would upgrade to a Buy if the stock convincingly breaks above its 52-week high of $70.41 on strong volume, signaling a resumption of the uptrend, or if the forward PE compresses below 18x without a deterioration in the earnings outlook. It would downgrade to a Sell if quarterly revenue growth turns negative or if the company guides EPS meaningfully below the consensus range. Relative to its own history and the embedded growth expectations, the stock is fairly valued to slightly overvalued at current levels.
Sign up to view all
BKR 12-Month Price Forecast
The outlook for BKR is a battle between compelling fundamentals and challenging momentum. The company's strong cash flow, profitability, and clear path to significantly higher earnings support a constructive long-term view. However, the market has front-run this story, embedding high expectations into a 23x forward PE. The recent severe underperformance suggests these expectations are being questioned. The base case of range-bound trading is most likely, as the company executes but struggles to provide new positive surprises to drive the multiple higher. The stance would upgrade to bullish on a confirmed breakout above $70.41 with strong volume, or downgrade to bearish on an earnings miss that breaks the $60 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Baker Hughes's 12-month outlook, with a consensus price target around $83.55 and implied upside of +30.0% versus the current price.
Average Target
$83.55
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$51 - $84
Analyst target range
Analyst coverage for Baker Hughes is robust, with data indicating at least 7 analysts providing estimates. The consensus leans bullish, as evidenced by a series of recent institutional ratings from major firms like Citigroup, Barclays, JP Morgan, and Jefferies maintaining 'Buy' or 'Overweight' equivalents in January and February 2026. While a specific average target price is not provided in the dataset, the sustained positive bias from numerous analysts, coupled with estimated EPS growth to $3.51 (from a trailing base of $0.0575), implies significant upside potential is expected by the street. The estimated EPS range for the forward period is $3.39 to $3.66, representing a relatively tight spread of about 7.8%, which suggests a higher degree of consensus and conviction among analysts regarding the company's earnings trajectory. The high-end estimate likely incorporates successful execution on strategic divestitures, market share gains in core segments, and a favorable commodity price environment. The low-end estimate may factor in potential margin compression, geopolitical volatility impacting project timelines, or a sharper-than-expected economic slowdown. The pattern of recent analyst actions shows stability, with no downgrades in the provided data, reinforcing a constructive outlook.
Bulls vs Bears: BKR Investment Factors
The evidence for Baker Hughes presents a classic tension between strong fundamentals and a challenging near-term technical/momentum picture. The bull case is anchored in exceptional projected earnings growth, robust cash generation, a fortified balance sheet, and a favorable strategic and geopolitical backdrop. The bear case highlights the stock's recent sharp underperformance, the high expectations embedded in its forward valuation, and its inherent cyclicality. Currently, the fundamental bull points carry stronger weight, given the concrete data on profitability, cash flow, and analyst conviction. However, the single most important tension in the investment debate is whether the company can deliver on the massive EPS growth (to $3.51) that the forward PE of 23x demands, or if the recent price weakness foreshadows a disappointment that triggers valuation compression.
Bullish
- Strong Free Cash Flow Generation: The company generates substantial free cash flow, with TTM FCF of $2.54 billion. This provides a robust financial foundation for dividends, share buybacks, and strategic investments without heavy reliance on debt.
- Analyst Consensus for Significant EPS Growth: Analysts project forward EPS of $3.51, a massive increase from the trailing EPS of $0.0575. The tight estimate range ($3.39-$3.66) and sustained 'Buy' ratings from major firms indicate high conviction in the earnings recovery story.
- Healthy Balance Sheet & Profitability: Baker Hughes maintains a strong financial position with a low debt-to-equity ratio of 0.38 and a current ratio of 1.36. Profitability is solid, evidenced by a Q4 2025 net margin of 11.9% and a robust ROE of 13.7%.
- Strategic Focus via Non-Core Divestiture: The recent $1.45 billion sale of the Waygate Technologies unit sharpens the company's focus on its core Oilfield Services & Equipment and Industrial & Energy Technology segments, potentially improving operational efficiency and capital allocation.
Bearish
- Severe Recent Relative Underperformance: The stock has declined 7.2% over the past month and 2.1% over three months, starkly underperforming the S&P 500 by -13.5 and -12.4 percentage points, respectively. This suggests waning momentum and potential sector-specific headwinds.
- Forward PE Expansion Signals High Expectations: The forward PE of 22.96x is significantly higher than the trailing PE of 17.4x, indicating the market has already priced in the anticipated EPS surge to $3.51. This leaves little room for error and creates valuation compression risk if growth disappoints.
- Modest Top-Line Growth Trajectory: Q4 2025 revenue grew only 0.3% year-over-year. While sequential quarterly improvement through 2025 is positive, the overall revenue growth rate remains modest, raising questions about the scalability of the earnings recovery.
- Cyclical Exposure and Macro Sensitivity: As an oilfield services company with a beta of 0.97, BKR's fortunes are tied to the energy investment cycle and broader economic conditions. A slowdown in global growth or a sharp drop in energy prices could quickly reverse recent gains.
BKR Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 71.0% 1-year price change, significantly outperforming the broader market's 28.2% gain. With a current price of $63.88, the stock is trading at approximately 91% of its 52-week high of $70.41, indicating strong momentum but also proximity to a key resistance level that may signal potential overextension or a test of investor conviction. The stock's beta of 0.97 suggests its volatility is nearly in line with the overall market, which is notable for a cyclical energy services name. Recent momentum has shown significant deceleration and divergence from the longer-term uptrend. The stock has declined 7.2% over the past month and 2.1% over the past three months, starkly contrasting with the S&P 500's gains of 6.3% and 10.3% over the same periods, resulting in severe relative weakness metrics of -13.5 and -12.4, respectively. This divergence suggests the stock is undergoing a significant correction or consolidation phase, potentially driven by profit-taking after its strong run or sector-specific headwinds. Key technical levels are clearly defined by the 52-week high of $70.41 as immediate resistance and the 52-week low of $36.53 as major support. A decisive breakout above $70.41 would signal a resumption of the primary uptrend, while a breakdown below the recent consolidation range around $60 could target lower support levels. The stock's beta near 1.0 indicates its moves are largely synchronized with the broader market, but the recent underperformance highlights idiosyncratic or sector-specific pressures that require monitoring.
Beta
0.97
0.97x market volatility
Max Drawdown
-16.9%
Largest decline past year
52-Week Range
$37-$70
Price range past year
Annual Return
+71.2%
Cumulative gain past year
| Period | BKR Return | S&P 500 |
|---|---|---|
| 1m | -6.9% | +5.0% |
| 3m | +6.8% | +10.7% |
| 6m | +30.6% | +10.0% |
| 1y | +71.2% | +26.5% |
| ytd | +36.3% | +10.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BKR Fundamental Analysis
Revenue growth has been modest but positive, with Q4 2025 revenue of $7.39 billion representing a slight 0.3% year-over-year increase. However, examining the quarterly sequence within 2025 shows a more encouraging trend: revenue grew sequentially from $6.43 billion in Q1 to $7.39 billion in Q4, indicating a steady recovery through the year. Segment data reveals a balanced contribution, with the Industrial & Energy Technology segment generating $3.81 billion and Oilfield Services & Equipment contributing $3.57 billion in the latest period, showcasing the company's dual-engine growth strategy. Profitability is solid, with the company reporting net income of $876 million and a net margin of 11.9% for Q4 2025. Gross margin for the quarter was 23.7%, while the operating margin stood at 13.1%. Comparing margins across recent quarters shows stability; for instance, Q3 2025 gross margin was 24.3% and Q2 was 23.4%, indicating disciplined cost management. The company is firmly profitable, with trailing twelve-month free cash flow of $2.54 billion providing strong evidence of earnings quality and cash conversion. The balance sheet and cash flow position are healthy. The company maintains a conservative debt-to-equity ratio of 0.38 and a current ratio of 1.36, indicating ample liquidity. Return on Equity (ROE) is a robust 13.7%, and Return on Assets (ROA) is 5.0%, demonstrating efficient use of capital. The substantial free cash flow generation of $2.54 billion TTM provides internal funding for growth initiatives, dividends (with a 2.0% yield), and potential share repurchases, reducing reliance on external financing and lowering financial risk.
Quarterly Revenue
$7.4B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BKR Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 17.4x, while the forward PE is 22.96x, based on estimated EPS of $3.51. The forward multiple's premium to the trailing multiple implies the market is pricing in expectations for significant earnings growth in the coming year, aligning with analyst estimates. Compared to the broader market and its historical context, the valuation appears reasonable. A trailing PE of 17.4x is not excessive for a company in a cyclical recovery with a 13.7% ROE. The stock's Price-to-Sales (PS) ratio of 1.62x and Enterprise Value-to-Sales (EV/Sales) of 2.32x provide additional context, suggesting the market values the company's revenue stream at a moderate multiple. The PEG ratio is negative at -1.37, but this is often distorted by near-term earnings fluctuations in cyclical industries and is less reliable than absolute multiples. Historically, the current trailing PE of 17.4x sits comfortably within its own historical range observed over recent years, which has seen significant swings from negative values during downturns to over 40x during recovery phases. It is notably lower than the 27.1x seen in Q1 2025 and the 19.7x in Q3 2025, suggesting the recent price correction has improved valuation attractiveness. Trading near the middle of its historical PE band indicates the market is balancing optimism about the energy cycle with realism about execution and macro risks.
PE
17.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -311x~658x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Baker Hughes's primary financial risk is not leverage or liquidity, given its strong balance sheet (D/E 0.38) and cash flow. Instead, the risk lies in earnings volatility and execution. The forward PE of 23x implies the market expects flawless execution to achieve the $3.51 EPS estimate. Any margin pressure—gross margin has fluctuated between 23.4% and 24.3% recently—or revenue growth deceleration below expectations could trigger significant multiple contraction. Furthermore, the company's operations are exposed to project delays and cost overruns inherent in large-scale energy projects, which could impact quarterly earnings consistency.
Market & Competitive Risks: The most salient market risk is valuation compression. The stock trades at a forward PE premium to its own trailing multiple, leaving it vulnerable if growth stock multiples contract or if the energy sector falls out of favor. Competitive intensity remains high as one of the 'Big Three' alongside SLB and Halliburton, pressuring pricing and market share. Geopolitical tensions, while a potential demand driver, also pose a direct operational risk if they disrupt projects in key regions like the Middle East, which accounts for a substantial portion of OFSE revenue.
Worst-Case Scenario: The worst-case scenario involves a combination of a global economic slowdown reducing energy demand, a resolution of Middle East tensions eroding the risk premium, and Baker Hughes missing its lofty earnings targets. This could lead to a rapid derating of the stock from its forward multiple. A realistic downside could see the stock re-testing its 52-week low of $36.53, which would represent a decline of approximately -43% from the current price of $63.88. The recent max drawdown of -16.86% over the provided period shows the stock is capable of sharp corrections even within an uptrend, underscoring this risk.
FAQ
The key risks are, in order of severity: 1) Execution/Earnings Risk: Failure to deliver on the projected $3.51 EPS could cause the 23x forward multiple to contract sharply. 2) Cyclical/Macro Risk: As a beta 0.97 stock in the energy sector, a downturn in global growth or energy prices would directly impact revenues and sentiment. 3) Geopolitical Risk: While currently a tailwind, an escalation or sudden de-escalation in Middle East tensions could cause volatile swings in the stock. 4) Competitive Risk: Intense competition with SLB and Halliburton could pressure pricing and market share.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $68 and $75, driven by meeting the $3.51 EPS consensus. The Bull Case (30% probability) targets $78 to $85 on superior execution and sustained geopolitical tensions. The Bear Case (15% probability) warns of a drop to $45-$55 on an earnings miss and sector derating. The most likely outcome is the Base Case, as it assumes the company delivers on current analyst expectations without major positive or negative surprises. The key assumption is the successful translation of modest revenue growth into the projected earnings surge.
BKR appears fairly valued to slightly overvalued based on forward earnings. The trailing P/E of 17.4x is reasonable, but the forward P/E of 22.96x indicates the market is paying a premium for expected earnings growth to $3.51 per share. This multiple implies high confidence in execution. Compared to its own historical P/E range, the current multiple is in the middle, suggesting the market is balancing optimism with realism. The valuation is not egregious, but it is not a discount; it fairly prices the company's recovery story, leaving little room for error.
BKR is a Hold, not a clear-cut buy at current levels. For investors already positioned, it represents a quality holding with strong fundamentals. For new money, the risk/reward is balanced. The potential upside to analyst-implied targets is meaningful, but it is offset by the stock's recent 7.2% monthly decline, its trading position at 91% of the 52-week high, and the high expectations embedded in its 23x forward P/E. It could be a good buy for patient, cyclical investors on a pullback toward the $60 support level, where the valuation would offer a better margin of safety.
BKR is more suitable for a medium-to-long-term investment horizon (12+ months) rather than short-term trading. Its thesis is based on a cyclical earnings recovery and strategic execution, which will unfold over several quarters. The stock's beta of 0.97 and recent volatility show it can be unpredictable in the short term. Furthermore, its 2.0% dividend yield adds a component of total return for longer-term holders. Given the need for the company to hit its earnings targets, a minimum holding period through the next two earnings reports is advised to properly assess the trajectory.
